[SLN] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
29-Sep-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- 14.61%
YoY- -9.37%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 3,643 5,722 3,414 3,156 2,701 3,144 -842 -
PBT -13,420 -9,572 -11,227 -12,052 -12,708 -9,870 -3,789 132.89%
Tax -1,481 -1,888 -1,793 -2,123 -1,080 -1,450 -1,838 -13.44%
NP -11,939 -7,684 -9,434 -9,929 -11,628 -8,420 -1,951 235.67%
Tax Rate - - - - - - - -
Total Cost 15,582 13,406 12,848 13,085 14,329 11,564 1,109 485.09%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -327.72 -134.29 -276.33 -314.61 -430.51 -267.81 231.71 -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.40 -0.26 -0.32 -0.33 -0.39 -0.29 -0.07 220.64%
EPS Diluted -0.40 -0.26 -0.32 -0.33 -0.39 -0.29 -0.07 220.64%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.